Abbott Laboratories (ABT) EV to CFO (2009 - 2026)

Abbott Laboratories has disclosed EV to CFO across 18 years of filings, most recently posting 61.12 for Q2 2026.

• In Q2 2026, EV to CFO fell 45.53% year-over-year to 61.12; the TTM figure through Jun 2026 stood at 15.35 (down 39.6% YoY), while the FY2025 annual figure was 21.89, down 0.58% from the prior year.
• EV to CFO came in at 61.12 for Q2 2026 at Abbott Laboratories, down from 130.93 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 186.64 in Q1 2024 to a low of 57.2 in Q3 2022.
• Average EV to CFO over 5 years is 98.2, with a median of 83.42 recorded in 2023.
• Year-over-year, EV to CFO soared 100.4% in 2023 and plunged 45.53% in 2026.
• Over 5 years, EV to CFO stood at 77.75 in 2022, then retreated by 22.13% to 60.55 in 2023, then gained by 8.52% to 65.7 in 2024, then declined by 3.85% to 63.17 in 2025, then retreated by 3.25% to 61.12 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 61.12 in Q2 2026, 130.93 in Q1 2026, and 63.17 in Q4 2025.